UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of May, 2018

Commission File Number 1-14840

 

 

AMDOCS LIMITED

 

 

Hirzel House, Smith Street,

St. Peter Port, Island of Guernsey, GY1 2NG

Amdocs, Inc.

1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

FORM 20-F  ☒            FORM 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

YES  ☐            NO  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-            

 

 

 


On May 10, 2018, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended March 31, 2017. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.

The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

AMDOCS LIMITED
By:  

/s/ Matthew E. Smith

  Matthew E. Smith
  Secretary and Authorized Signatory

Date: May 10, 2018


EXHIBIT INDEX

 

EXHIBIT

    NO.    

  

DESCRIPTION

99.1    Amdocs Limited Press Release dated May 10, 2018.


Exhibit 99.1

 

LOGO

 

 

Amdocs Limited Reports Second Quarter Fiscal 2018 Results

Record Quarterly Revenue of $992M

Expects Fiscal 2018 GAAP Diluted EPS Growth Outlook of 0.0%-6.0% YoY

Reiterates Fiscal 2018 Non-GAAP Diluted EPS Growth Outlook of 4.0%-8.0% YoY

Second Quarter Fiscal 2018 Highlights

 

    Closed the previously announced acquisition of Vubiquity for $224 million in cash and acquired UXP Systems for $80 million in cash

 

    Revenue of $992 million, within the $960-$1,000 million guidance range; revenue included a positive impact from foreign currency movements relative to the first quarter of fiscal 2018, and contributions from M&A consummated this quarter

 

    GAAP diluted EPS of $0.70, above the midpoint of the $0.65-$0.73 guidance range

 

    Non-GAAP diluted EPS of $0.95, above the midpoint of the $0.91-$0.97 guidance range

 

    GAAP operating income of $132 million; GAAP operating margin of 13.3%

 

    Non-GAAP operating income of $172 million; non-GAAP operating margin of 17.3%

 

    Free cash flow of $3 million, comprised of cash flow from operations of $114 million, less $111 million in net capital expenditures and other, of which $81 million related to the multi-year development of the new campus. Excluding the campus investment, normalized free cash flow was $84 million in the second quarter of fiscal 2018

 

    Twelve-month backlog of $3.32 billion, up $60 million sequentially

 

    Quarterly cash dividend of $0.25 per share, to be paid on July 20, 2018


ST. LOUIS – May 10, 2018 – Amdocs Limited (NASDAQ: DOX) today reported operating results for the three months ended March 31, 2018.

“We are pleased to report solid results for our second fiscal quarter which included double-digit growth in Europe and record revenue in Rest of World. Our operating profitability was stable and we grew our 12-month backlog to another new high. Additionally, we extended our technology leadership with the launch of AmdocsOne at Mobile World Congress and we utilized our cash to close on the acquisitions of Vubiquity, as well as UXP Systems, a leader in User Lifecycle Management solutions,” said Eli Gelman, president and chief executive officer of Amdocs Management Limited.

Gelman continued, “Rest of World was a highlight of the quarter as we focused on project execution and securing new awards. In Southeast Asia, we commenced the ramp-up of the seven-year project and managed services agreement we signed with PLDT earlier in Q2. Additionally, we made an important step in Africa where we were selected to provide our revenue assurance capabilities to Safaricom, a major mobile network operator in Kenya with nearly 30 million subscribers.”

Gelman concluded, “We enter Q3 on-track to deliver a stronger second half, although we are of course monitoring the many moving parts affecting our outlook, including those resulting from consolidation activity currently in progress across our main operating regions. Additionally, we are focused on our execution and profitability, which combined with expected normalized free cash flow generation of approximately $500 million for the full year, leaves us well positioned to deliver diluted non-GAAP earnings per share growth in the range of 4% to 8% in fiscal 2018.”

Revenue

 

    Revenue for the second fiscal quarter ended March 31, 2018 was $992.3 million, up 1.5% or $14.6 million sequentially from the first fiscal quarter of 2018 and up 2.7% as compared to last year’s second fiscal quarter. Revenue for the second fiscal quarter of 2018 includes a positive impact from foreign currency movements of approximately $5 million relative to the first quarter of fiscal 2018 and contributions from M&A consummated in the second fiscal quarter.


Net Income and Earnings Per Share

The Company’s GAAP net income for the second quarter of fiscal 2018 was $101.7 million, or $0.70 per diluted share, compared to GAAP net income of $112.6 million, or $0.76 per diluted share, in the prior fiscal year’s second quarter. Net income on a non-GAAP basis was $137.4 million, or $0.95 per diluted share, compared to non-GAAP net income of $139.2 million, or $0.94 per diluted share, in the second quarter of fiscal 2017.

Returning Cash to Shareholders

 

    Quarterly Cash Dividend Program: On May 10, 2018, the Board approved the Company’s next quarterly cash dividend payment of $0.25 per share and set June 29, 2018 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on July 20, 2018.

 

    Share Repurchase Activity: Repurchased $120 million of ordinary shares during the second quarter of fiscal 2018.

Twelve-month Backlog

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.32 billion at the end of the second quarter of fiscal 2018, up $60 million from the end of the prior quarter.

Third Quarter Fiscal 2018 Outlook

 

    Revenue of approximately $990-$1,030 million, including an immaterial sequential impact from foreign currency fluctuations as compared to the second quarter of fiscal 2018. Third quarter fiscal 2018 guidance incorporates full quarter contributions from recently closed acquisitions

 

    Diluted GAAP EPS of approximately $0.71-$0.81. The impact on diluted GAAP EPS of the acquisition of Vubiquity and UXP Systems is subject to finalization of the purchase price allocation and of the anticipated acquisition-related expenses related to operating adjustments, restructuring charges and other acquisition-related costs.

 

    Diluted non-GAAP EPS of approximately $1.00-$1.06, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.07 per share of equity-based compensation expense, net of related tax effects. Expected non-GAAP effective tax rate around the low-end of the annual target range of 13%-17% in the third quarter fiscal 2018


Full Year Fiscal 2018 Outlook

 

    Expects revenue growth of 2.3%-4.3% year-over-year as reported compared with previous guidance of 0.0%-4.0% year-over-year

 

    Expects revenue growth of 1.3%-3.3% year-over-year on a constant currency basis compared with previous guidance of (1.0%)-3.0% year-over-year

 

    Full year fiscal 2018 revenue guidance incorporates an incremental revenue contribution of more than 1% from Vubiquity on both a constant currency and reported basis, and an expected positive impact from foreign currency fluctuations of about 1% year-over-year

 

    Expects GAAP diluted earnings per share growth of roughly 0.0%-6.0% year-over-year. The impact on diluted GAAP EPS of the acquisition of Vubiquity and UXP Systems is subject to finalization of the purchase price allocation and of the anticipated expenses related to operating adjustments, restructuring charges and other acquisition-related costs

 

    Reiterates Non-GAAP diluted earnings per share growth of roughly 4.0%-8.0% year-over-year, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.26-$0.29 per share of equity-based compensation expense, net of related tax effects. Expected non-GAAP effective tax rate to remain within the same target range of 13%-17% for the full year fiscal 2018

 

    The impact of recent acquisitions on Amdocs’ diluted non-GAAP earnings per share (excluding amortization of purchased intangible assets, restructuring charges, other acquisition-related costs and equity based compensation expense, net of related tax effects) is expected to be neutral in fiscal year 2018, and accretive thereafter

Our third fiscal quarter 2018 and full year fiscal 2018 outlook takes into consideration the Company’s expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call.


However, Amdocs notes market dynamics continue to shift rapidly and that it cannot predict all possible outcomes, including those resulting from AT&T’s proposed merger with Time Warner, T-Mobile’s proposed merger with Sprint, or from other current and potential customer consolidation activity in North America.

Conference Call Details

Amdocs will host a conference call on May 10, 2018 at 5:00 p.m. Eastern Time to discuss the Company’s second quarter of fiscal 2018 results. To participate, please dial +1 (844) 513-7152, or +1 (508) 637-5600 outside the United States, approximately 15 minutes before the call and enter passcode 4175387. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

 

    amortization of purchased intangible assets and other acquisition-related costs;

 

    changes in fair value of certain acquisition-related liabilities;

 

    nonrecurring restructuring charges;

 

    equity-based compensation expense; and

 

    tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.


Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in fair value of certain acquisition-related liabilities, equity-based compensation expense and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.


Supporting Resources

 

  Keep up with Amdocs news by visiting the Company’s website

 

  Subscribe to Amdocs’ RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube

About Amdocs

Amdocs is a leading software and services provider to the world’s most successful communications and media companies. As our customers reinvent themselves, we enable their digital and network transformation through innovative solutions, delivery expertise and intelligent operations. Amdocs and its 25,000 employees serve customers in over 85 countries. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $3.9 billion in fiscal 2017.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to


update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2017 filed on December 11, 2017 and our Form 6-K furnished for the first quarter of fiscal 2018 on February 12, 2018.

Contact:

Matthew Smith

Head of Investor Relations

Amdocs

314-212-8328

E-mail: dox_info@amdocs.com


AMDOCS LIMITED

Consolidated Statements of Income

(in thousands, except per share data)

 

     Three months ended      Six months ended  
     March 31,      March 31,  
     2018      2017      2018      2017  

Revenue

   $ 992,340      $ 966,009      $ 1,970,051      $ 1,920,736  

Operating expenses:

           

Cost of revenue

     646,587        621,737        1,289,784        1,242,571  

Research and development

     64,926        67,303        133,103        127,293  

Selling, general and administrative

     120,199        114,465        238,867        238,544  

Amortization of purchased intangible assets and other

     28,801        28,723        54,327        56,954  
  

 

 

    

 

 

    

 

 

    

 

 

 
     860,513        832,228        1,716,081        1,665,362  
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income

     131,827        133,781        253,970        255,374  

Interest and other expense, net

     239        468        118        3,231  
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before income taxes

     131,588        133,313        253,852        252,143  

Income taxes

     29,861        20,753        35,252        41,790  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 101,727      $ 112,560      $ 218,600      $ 210,353  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic earnings per share

   $ 0.71      $ 0.77      $ 1.52      $ 1.43  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted earnings per share

   $ 0.70      $ 0.76      $ 1.51      $ 1.42  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic weighted average number of shares outstanding

     143,030        146,595        143,487        146,706  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted weighted average number of shares outstanding

     144,390        147,954        144,882        148,168  
  

 

 

    

 

 

    

 

 

    

 

 

 

Cash dividends declared per share

   $ 0.250      $ 0.220      $ 0.470      $ 0.415  
  

 

 

    

 

 

    

 

 

    

 

 

 


AMDOCS LIMITED

Selected Financial Metrics

(in thousands, except per share data)

 

     Three months ended      Six months ended  
     March 31,      March 31,  
     2018      2017      2018      2017  

Revenue

   $ 992,340      $ 966,009      $ 1,970,051      $ 1,920,736  

Non-GAAP operating income

     171,760        165,997        340,824        330,082  

Non-GAAP net income

     137,350        139,164        291,816        272,731  

Non-GAAP diluted earnings per share

   $ 0.95      $ 0.94      $ 2.01      $ 1.84  

Diluted weighted average number of shares outstanding

     144,390        147,954        144,882        148,168  


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

 

     Three months ended
March 31, 2018
 
            Reconciliation items        
     GAAP      Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in fair
value of certain
acquisition-
related liabilities
    Tax effect     Non-GAAP  

Operating expenses:

             

Cost of revenue

   $ 646,587      $ —       $ (4,727   $ (574   $ —       $ 641,286  

Research and development

     64,926        —         (769     —         —         64,157  

Selling, general and administrative

     120,199        —         (5,062     —         —         115,137  

Amortization of purchased intangible assets and other

     28,801        (28,801     —         —         —         —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     860,513        (28,801     (10,558     (574     —         820,580  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     131,827        28,801       10,558       574       —         171,760  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     29,861        —         —         —         4,310       34,171  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 101,727      $ 28,801     $ 10,558     $ 574     $ (4,310   $ 137,350  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   
     Three months ended
March 31, 2017
 
            Reconciliation items        
     GAAP      Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in fair
value of certain
acquisition-
related liabilities
    Tax effect     Non-GAAP  

Operating expenses:

             

Cost of revenue

   $ 621,737      $ —       $ (4,973   $ 6,691     $ —       $ 623,455  

Research and development

     67,303        —         (901     —         —         66,402  

Selling, general and administrative

     114,465        —         (4,310     —         —         110,155  

Amortization of purchased intangible assets and other

     28,723        (28,723     —         —         —         —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     832,228        (28,723     (10,184     6,691       —         800,012  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     133,781        28,723       10,184       (6,691     —         165,997  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     20,753        —         —         —         5,612       26,365  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 112,560      $ 28,723     $ 10,184     $ (6,691   $ (5,612   $ 139,164  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

 

     Six months ended
March 31, 2018
 
            Reconciliation items        
     GAAP      Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in
fair value
of certain
acquisition-
related
liabilities
    Tax effect     One-time tax
benefit
relating to
the new U.S.
tax
legislation
    Non-GAAP  

Operating expenses:

               

Cost of revenue

   $ 1,289,784      $ —       $ (9,425   $ (8,464   $ —       $ —       $ 1,271,895  

Research and development

     133,103        —         (1,593     —           —         131,510  

Selling, general and administrative

     238,867        —         (13,045     —           —         225,822  

Amortization of purchased intangible assets and other

     54,327        (54,327     —         —           —         —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     1,716,081        (54,327     (24,063     (8,464       —         1,629,227  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     253,970        54,327       24,063       8,464         —         340,824  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     35,252        —         —         —         10,688       2,950       48,890  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 218,600      $ 54,327     $ 24,063     $ 8,464     $ (10,688   $ (2,950   $ 291,816  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

 

     Six months ended
March 31, 2017
 
            Reconciliation items        
     GAAP      Amortization
of purchased
intangible
assets and
other
    Equity based
compensation
expense
    Changes in
fair value
of certain
acquisition-
related
liabilities
    Tax effect     Non-GAAP  

Operating expenses:

             

Cost of revenue

   $ 1,242,571      $ —       $ (9,971   $ 6,691     $ —       $ 1,239,291  

Research and development

     127,293        —         (1,800     —         —         125,493  

Selling, general and administrative

     238,544        —         (12,674     —         —         225,870  

Amortization of purchased intangible assets and other

     56,954        (56,954     —         —         —         —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     1,665,362        (56,954     (24,445     6,691       —         1,590,654  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     255,374        56,954       24,445       (6,691     —         330,082  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     41,790        —         —         —         12,330       54,120  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 210,353      $ 56,954     $ 24,445     $ (6,691   $ (12,330   $ 272,731  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(in thousands)

 

     As of  
     March 31,
2018
     September 30,
2017
 

ASSETS

     

Current assets

     

Cash, cash equivalents and short-term interest-bearing investments

   $ 666,843      $ 979,608  

Accounts receivable, net, including unbilled of $249,377 and $229,695, respectively

     972,279        865,068  

Prepaid expenses and other current assets

     221,825        203,810  
  

 

 

    

 

 

 

Total current assets

     1,860,947        2,048,486  

Property and equipment, net

     471,818        355,685  

Goodwill and other intangible assets, net

     2,780,956        2,398,535  

Other noncurrent assets

     465,270        476,674  
  

 

 

    

 

 

 

Total assets

   $ 5,578,991      $ 5,279,380  
  

 

 

    

 

 

 

LIABILITIES AND EQUITY

     

Current liabilities

     

Accounts payable, accruals and other

   $ 1,141,799      $ 1,059,855  

Short-term financing arrangements

Deferred revenue

    

120,000

128,556

 

 

    

—  

113,091

 

 

  

 

 

    

 

 

 

Total current liabilities

     1,390,355        1,172,946  

Other noncurrent liabilities

     582,419        532,364  

Total Amdocs Limited Shareholders’ equity

     3,563,054        3,574,070  

Noncontrolling interests

     43,163        —    
  

 

 

    

 

 

 

Total equity

   $ 3,606,217      $ 3,574,070  
  

 

 

    

 

 

 

Total liabilities and equity

   $ 5,578,991      $ 5,279,380  
  

 

 

    

 

 

 


AMDOCS LIMITED

Consolidated Statements of Cash Flows

(in thousands)

 

     Six months ended March 31,  
     2018     2017  

Cash Flow from Operating Activities:

    

Net income

   $ 218,600     $ 210,353  

Reconciliation of net income to net cash provided by operating activities:

    

Depreciation and amortization

     102,900       109,038  

Equity-based compensation expense

     24,063       24,445  

Deferred income taxes

     (3,584     16,889  

Excess tax benefit from equity-based compensation

     —         (2,929

loss (Gain) from short-term interest-bearing investments

     1,195       (17

Net changes in operating assets and liabilities, net of amounts acquired:

    

Accounts receivable, net

     (77,359     (25,092

Prepaid expenses and other current assets

     (9,509     (10,926

Other noncurrent assets

     (10,606     (42,294

Accounts payable, accrued expenses and accrued personnel

     23,103       25,101  

Deferred revenue

     8,600       (19,932

Income taxes payable, net

     8,675       (8,813

Other noncurrent liabilities

     (7,749     (469
  

 

 

   

 

 

 

Net cash provided by operating activities

     278,329       275,354  
  

 

 

   

 

 

 

Cash Flow from Investing Activities:

    

Purchase of property and equipment

     (162,126     (69,906

Proceeds from sale of short-term interest-bearing investments

     207,738       144,920  

Purchase of short-term interest-bearing investments

     (76,037     (145,737

Net cash paid for acquisitions

     (352,599     —    

Other

     (3,446     1,671  
  

 

 

   

 

 

 

Net cash used in investing activities

     (386,470     (69,052
  

 

 

   

 

 

 

Cash Flow from Financing Activities:

    

Borrowings under financing arrangements

     120,000       200,000  

Payments under financing arrangements

     —         (200,000

Repurchase of shares

     (239,779     (160,232

Investment by noncontrolling interest, net

     47,013       —    

Proceeds from employee stock options exercised

     65,631       62,368  

Payments of dividends

     (63,294     (57,299

Excess tax benefit from equity-based compensation and other

     (110     2,929  
  

 

 

   

 

 

 

Net cash used in financing activities

     (70,539     (152,234
  

 

 

   

 

 

 

Net (decrease) increase in cash and cash equivalents

     (178,680     54,068  

Cash and cash equivalents at beginning of period

     649,611       768,660  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 470,931     $ 822,728  
  

 

 

   

 

 

 


AMDOCS LIMITED

Supplementary Information

(In millions)

 

     Three months ended  
     March 31,
2018
     December 31,
2017
     September 30,
2017
     June 30,
2017
     March 31,
2017
 

North America

   $ 624.2      $ 643.0      $ 644.1      $ 637.9      $ 636.3  

Europe

     148.6        133.7        129.8        125.2        115.4  

Rest of World

     219.5        201.0        205.8        203.6        214.3  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 992.3      $ 977.7      $ 979.7      $ 966.7      $ 966.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     Three months ended  
     March 31,
2018
     December 31,
2017
     September 30,
2017
     June 30,
2017
     March 31,
2017
 

Managed Services Revenue

   $ 508.9      $ 518.7      $ 503.8      $ 496.3      $ 511.1  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     Three months ended  
     March 31,
2018
     December 31,
2017
     September 30,
2017
     June 30,
2017
     March 31,
2017
 

Customer Experience Solutions

   $ 980.7      $ 965.9      $ 967.7      $ 954.8      $ 948.6  

Directory

     11.6        11.8        12.0        11.9        17.4  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 992.3      $ 977.7      $ 979.7      $ 966.7      $ 966.0  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     As of  
     March 31,
2018
     December 31,
2017
     September 30,
2017
     June 30,
2017
     March 31,
2017
 

12-Month Backlog

   $ 3,320      $ 3,260      $ 3,250      $ 3,220      $ 3,210  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

# # #